MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517035506 A) filed by Technische Universitat Munchen; and Universitat Augsburg, Munchen, Germany, on April 11, for 'novel minigastrin derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy.'
Inventor(s) include Gunther Thomas; Holzleitner Nadine; Wester Hans Jurgen; and Lapa Constantin.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a tetrapeptide binding to Cholecystokinin 2 receptor (CCK 2R) wherein the tetrapeptide is represented by formula (I) Xaa1 Xaa2 Xaa3 Xaa4 (formula (...